Giovanna F.
- Country
- Italy
- Department
- Oncologia Medica ed Ematologia
Research Overview
- Phase 3 Evaluation of Pembrolizumab and Olaparib with Chemoradiation in Unresectable Stage III Non-Small Cell Lung Cancer
- Phase 3 Randomized Study of Tarlatamab Versus Placebo in Limited-Stage Small-Cell Lung Cancer Post-Concurrent Chemoradiation Therapy
- A Phase III, Randomized, Controlled, Multi-center, 3-Arm Study of Neoadjuvant Osimertinib as Monotherapy or in Combination with Chemotherapy versus Standard of Care Chemotherapy Alone for the Treatment of Patients with Epidermal Growth Factor Receptor Mutation Positive, Resectable Non-small Cell Lung Cancer (NeoADAURA)
Data & Insights
Has run more than one trial at 175 of 375 partner sites.
Specializations
Advanced Lung Cancer Treatment
The investigator specializes in treating various forms of non-small cell lung cancer (NSCLC), with particular emphasis on advanced and metastatic stages of the disease.
- Stage III NSCLC Management
- Metastatic Squamous NSCLC
- EGFR-Mutated Advanced NSCLC
Clinical focus includes evaluating novel therapeutic approaches for both early-stage and advanced disease states.
Innovative Therapeutic Approaches
Expertise in developing and implementing combination therapy strategies, particularly involving immunotherapy and targeted treatments.
- Chemoradiation Therapy Combinations
- Immunotherapy Applications
- Targeted Molecular Therapies
Interest in evaluating novel drug delivery methods and therapeutic combinations for optimal patient outcomes.
Specialized Cancer Care
Focus on treating both small cell lung cancer (SCLC) and various subtypes of non-small cell lung cancer, with expertise in personalized treatment approaches.
- Treatment-Resistant Disease
- Second-Line Therapy Development
- Novel Treatment Evaluation
Dedicated to advancing treatment options for patients with complex or progressive disease states.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.